By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics today raised the total offering for its proposed initial public offering to as much as $96.6 million from its original goal of $86.3 million.

In an amended S-1 form filed with the US Securities and Exchange Commission, the Mountain View, Calif., sequencing services firm also reported preliminary earnings for the quarter ended Sept. 30.

For its IPO, Complete Genomics plans to offer 6 million shares at a share price between $12 and $14.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.